INmune Bio

(NASDAQ) INMB

Current Price$1.44

Market Cap$37.75M

Since IPO (2019)-82%

5 Year-93%

1 Year-77%

1 Month+1%

INmune Bio Financials at a Glance

Market Cap

$37.75M

Revenue (TTM)

$0.00

Net Income (TTM)

-$41.60M

EPS (TTM)

-$1.69

P/E Ratio

-0.84

Dividend

$0.00

Beta (Volatility)

1.55 (High)

Dividend

$0.00

Beta (Volatility)

1.55 (High)

Price

$1.44

Volume

48,012

Open

$1.49

Price

$1.44

Volume

48,012

Open

$1.49

Previous Close

$1.44

Daily Range

$1.43 - $1.59

52-Week Range

$1.09 - $3.24

Estimated Earnings Date

Aug 6, 2026

Dividend

$0.00

Beta (Volatility)

1.55 (High)

Price

$1.44

Volume

48,012

Open

$1.49

Previous Close

$1.44

Daily Range

$1.43 - $1.59

52-Week Range

$1.09 - $3.24

Estimated Earnings Date

Aug 6, 2026

INMB News

INmune Bio (INMB) Q2 Loss Widens 110%

Motley Fool Markets TeamAug 7, 2025

Why INmune Bio Stock Soared Then Sank Today

Keith SpeightsJan 21, 2021

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About INmune Bio

Industry

Biotechnology

Sector

Health Care

Employees

CEO

David J. Moss, MBA

Website

www.inmunebio.com

Headquarters

Boca Raton, FL 33432, US

INMB Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-170.86%

Return on Capital

-125.70%

Return on Assets

-161.13%

Earnings Yield

-1.19%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$37.75M

Shares Outstanding

26.59M

Volume

48.01K

Avg. Volume

602.87K

Financials (TTM)

Gross Profit

-$108.00K

Operating Income

-$43.29M

EBITDA

-$25.09M

Operating Cash Flow

-$19.17M

Capital Expenditure

-$1.60M

Free Cash Flow

-$20.78M

Cash & ST Invst.

$21.36M

Total Debt

$1.51M

INmune Bio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

-$52.00K

-204.0%

Gross Margin

0.00%

N/A

Market Cap

$37.75M

N/A

Market Cap/Employee

$2.90M

N/A

Employees

N/A

Net Income

-$5.41M

+44.5%

EBITDA

-$5.36M

+45.0%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$21.36M

+10.5%

Total Debt

$1.51M

+335.2%

Accounts Receivable

$770.00K

-45.6%

Inventory

$0.00

N/A

Long Term Debt

$806.00K

+301.0%

Short Term Debt

$704.00K

+382.2%

Return on Assets

-1.61%

N/A

Return on Invested Capital

-2.12%

N/A

Free Cash Flow

-$3.40M

+50.1%

Operating Cash Flow

-$3.40M

+50.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

FGENFibroGen, Inc.

FGENFibroGen, Inc.$9.07-1.63%

ALGSAligos Therapeutics, Inc.

ALGSAligos Therapeutics, Inc.$5.57+1.27%

BRNSBarinthus Biotherapeutics plc

BRNSBarinthus Biotherapeutics plc$0.70-2.64%

PDSBPDS Biotechnology Corporation

PDSBPDS Biotechnology Corporation$0.89-0.62%

SKYESkye Bioscience, Inc.

SKYESkye Bioscience, Inc.$0.68-4.02%

OKUROnKure Therapeutics, Inc.

OKUROnKure Therapeutics, Inc.$4.50+6.64%

TPSTTempest Therapeutics, Inc.

TPSTTempest Therapeutics, Inc.$1.08+2.86%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.87+0.02%

KEELKeel Infrastructure

KEELKeel Infrastructure$6.03+0.03%

HLHecla Mining

HLHecla Mining$15.54+0.03%

INTCIntel

INTCIntel$128.32-0.03%

SOFISoFi Technologies

SOFISoFi Technologies$17.88+0.03%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.67+0.04%

TAT&T

TAT&T$22.72+0.01%

Questions About INMB

What is the current price of INmune Bio?

INmune Bio is trading at $1.44 per share.

What is the 52-week range for INmune Bio?

Over the past 52 weeks, INmune Bio has traded between $1.09 and $3.24.

How much debt does INmune Bio have?

As of the most recent reporting period, INmune Bio reported total debt of $1.51M.

How much cash does INmune Bio have on hand?

INmune Bio reported $21.36M in cash and cash equivalents in its most recent financial results.

What is INmune Bio’s dividend yield?

INmune Bio does not currently have a dividend yield.

INmune Bio

INmune Bio Financials at a Glance

INMB News

INmune Bio (INMB) Q2 Loss Widens 110%

Why INmune Bio Stock Soared Then Sank Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About INmune Bio

INMB Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

INmune Bio Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About INMB

What is the current price of INmune Bio?

What is the 52-week range for INmune Bio?

How much debt does INmune Bio have?

How much cash does INmune Bio have on hand?

What is INmune Bio’s dividend yield?

Premium Investing Services